
- Dermatology Times, July 2019 (Vol. 40, No. 7)
- Volume 40
- Issue 7
Video: Manage injection site reactions with patient education
In this Medical News Minute, Dr. Bobby Lazzara discusses the specifics regarding injection site reactions.
In this Medical News Minute, Dr. Bobby Lazzara discusses the specifics regarding injection site reactions.
First off, there are many types of injection site reactions - each with a constellation of symptoms, and they are all a local phenomenon.
Injection site reactions can be a major complication of all FDA approved self-injectable biological agents and biosimilars licensed for dermatological conditions in adults and children. In fact, incidence rate has been put at 40%.
But there is no correlation with drug efficacy or the production of anti-drug antibodies. Dr. Lazzara warns, "Don't discontinue treatment thinking allergic or immunologic reaction."
However, authors of a recent study, highlighted in this video, say almost all injection site reactions can be managed with proper patient engagement, education, and training around proper injection site techniques.
Articles in this issue
over 6 years ago
5 Insights on launching a new practiceover 6 years ago
Imaging techniques advance skin cancer managementover 6 years ago
Lasers aid actinic keratoses treatmentover 6 years ago
Mechanisms driving melanoma immunotherapyover 6 years ago
Studies don’t change sunscreen guidanceover 6 years ago
Is sunscreen hurting the environment?over 6 years ago
Can treating warts do more harm than good?over 6 years ago
The case for hackathons in dermatologyover 6 years ago
Dermatology Times at 40 yearsover 6 years ago
Reflections on the 40th Anniversary of Dermatology TimesNewsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















